Biotech stocks drop 10% due to FDA uncertainty

Market overview

Investor confidence in biotech firms will decline as the FDA leadership crisis raises concerns over delayed approvals and regulatory unpredictability. Major biotech indices will underperform the broader market by at least 10% within 6 months.

price prediction market

Implied probability (Yes)

68%

More price markets

• Samsung Electronics market cap to exceed $1.2T by Q3 2026 — 78% Yes
• Cisco stock to rise above $65 by Q3 2026 — 72% Yes
• Private jet charter prices increase 20% in 2027 — 75% Yes
• Google Messages sees 30% user growth in 6 months post-launch — 70% Yes
• US AI chip ETF doubles in value by 2026-09-30 — 65% Yes
• X’s stock price rises 10% within 3 months of History tab launch — 55% Yes
• TSK enters top 5 Spanish engineering firms by market cap — 60% Yes
• Ford stock volatility exceeds 60% annualized within 6 months — 75% Yes

Browse all price markets →